Rating History for Blueprint Medicines (BPMC) by Wells Fargo
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/17/2025 | Derek Archila | Downgrade | Equal Weight (Overweight) |
129.00 (N/A) |
128.25 (129.46) |
0.94% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
